WebCytoTools has effective processes in place that helps in exploring new product needs, doing quick pilot testing, and then launching the products quickly using its extensive distribution network. Low bargaining power of suppliers – Suppliers of CytoTools in the Healthcare sector have low bargaining power. WebCytoTools AG, a biotechnology company, develops a pipeline of disease modifying therapies. The company's therapies include proprietary small molecules and biologics to provide treatment options in dermatology, cardiology and angiology, urology, and oncology.
CYTOTOOLS AKTIE T5O Aktienkurs DE000A0KFRJ1
WebMay 19, 2024 · Cytotools Aktie: Das ist einfach klasse! Cytotools in der Fundamentalbewertung Derzeit liegt das Kurs-Gewinn-Verhältnis bei 21,99. Das bedeutet, für jeden Euro Gewinn von Cytotools zahlt die Börse 21,99 Euro. Dies sind 43 Prozent weniger als für vergleichbare Werte in der Branche gezahlt werden. Im Bereich … WebFeb 27, 2024 · CytoTools is a biotechnology company that develops disease modifying therapies. The Company's therapies include proprietary small molecules and biologics … black and white dining sets
CytoTools AG: Clinical Development Program For The Wound …
WebFeb 27, 2024 · CytoTools is a biotechnology company that develops disease modifying therapies. The Company's therapies include proprietary small molecules and biologics which provide treatment options in dermatology, cardiology, angiology, urology, and oncology. Type Public Status Active HQ Darmstadt, DE view all locations Website … WebCytoTools AG is an investment and holding company in the technology sector. It originated from CytoTools GmbH, a successful German technology enterprise from the pharmaceuticals and medical products field. Contact Information Website www.cytotools.de Formerly Known As CytoTools GmbH Ownership Status Publicly Held Financing Status … WebJun 23, 2014 · CytoTools AG participated in this round with approximately EUR 0.3 million, thus maintaining its stake in CytoPharma GmbH at significantly above 40%. The additional liquidity will enable CytoTools AG to continue to support the successful research activities at this subsidiary. It will begin to plan implementation of its existing cardiovascular ... black and white dining room walls